Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
about
Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysisRotavirus vaccines in routine useVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraeRotavirus vaccines: current status and future considerationsEffectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trialCharacterization of a G1P[8] rotavirus causing an outbreak of gastroenteritis in the Northern Territory, Australia, in the vaccine era.Accelerating the introduction of rotavirus immunization in Indonesia.Demographic buffering: titrating the effects of birth rate and imperfect immunity on epidemic dynamics.Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016.Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study.Issues in pediatric vaccine-preventable diseases in low- to middle-income countriesDynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design.Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies.Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua.Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil.Reduced rotavirus vaccine effectiveness among children born during the rotavirus season: a pooled analysis of 5 case-control studies from the Americas.Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors.Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction
P2860
Q26741847-28F95057-C668-43F1-B616-FEBBE62AA9A9Q26853690-92E03814-7EE7-498F-865E-1F38F240A105Q27004488-C1883682-4CB6-4668-900D-963102A7D00EQ27021385-243C1497-EB43-4DD2-974A-B593C441690AQ33574342-C2E58989-4AD7-4292-AC3E-2B81C1F87DD5Q34018952-C402AA7E-7A79-4DED-A522-40E8E676E4AAQ35104621-FCC3D6D0-4EEE-4EF0-A9B9-73616D135D7DQ35134368-865A3A2B-BF56-45D0-8A16-E2B556C4D62FQ36249319-E6B8C7BB-0CA4-4CE5-B3EB-F5463386CEC2Q36356363-4E165CCA-654B-4A24-BCE1-68CD971EC0E8Q36942818-4E8CDC73-5570-4C92-B95F-F8652A845D05Q37264972-0216CFFA-59B9-4C9C-BD02-612CA2EAB576Q37448980-AE548886-B6A6-400B-A0C9-ACBD4C3755E2Q37499028-5374E6C6-2D95-4FC7-8E54-4872DA907E13Q38168901-202A3552-5889-411F-9E5D-779EE6D1E84CQ38623481-7EAEC6B5-0299-408C-9BF6-62844136241AQ38907201-FC64C664-A90E-46BB-BB09-0B8643A070F6Q40722649-CA4463B5-9799-49BC-B54C-01BDF04F7482Q40722658-55FA809C-2E85-42D8-9C6C-93B5BD0B26E3Q41329103-8C8C5FC3-2DD0-4733-8F4C-ED9AB3FC4CBEQ41632202-427E2304-96C3-4618-A360-233BC06A6478Q47291480-82E79009-B40B-4B59-AC1C-87F696FF7636Q51660857-CDECF577-E079-412B-A0D7-700BE9D665D5Q59134865-0923BD4F-4473-47A7-9D2C-EA11AFFC5979
P2860
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@ast
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@en
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@nl
type
label
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@ast
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@en
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@nl
prefLabel
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@ast
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@en
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@nl
P2093
P356
P1433
P1476
Duration of protection of pentavalent rotavirus vaccination in Nicaragua.
@en
P2093
Alcides Gonzalez
Angel Balmaceda
Cristina Pedreira
Edmundo Sanchez
Jacqueline Tate
Jazmina Umaña
Jon Andrus
Juan Mercado
Lucia Helena De Oliveira
Manish Patel
P304
P356
10.1542/PEDS.2011-3478
P407
P577
2012-07-02T00:00:00Z